[Biojava-dev] Subversion
mark.schreiber at group.novartis.com
mark.schreiber at group.novartis.com
Sun Sep 26 21:24:08 EDT 2004
While I'm in a ranting mood,
What do people think about moving our CVS base to subversion?? The webDAV
protocol seems a lot nicer than CVS. Particularly where firewalls are
involved.
Any thoughts?
- Mark
Mark Schreiber
Principal Scientist (Bioinformatics)
Novartis Institute for Tropical Diseases (NITD)
10 Biopolis Road
#05-01 Chromos
Singapore 138670
www.nitd.novartis.com
phone +65 6722 2973
fax +65 6722 2910
More information about the biojava-dev
mailing list